Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?
The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market has demonstrated robust growth in recent years. This market is projected to expand from $1.18 billion in 2025 to $1.28 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.0%. Historically, this expansion has been driven by factors such as the increasing global incidence of HSV infections, heightened public understanding of sexually transmitted infections, the proliferation of molecular diagnostic laboratories, the rising uptake of nucleic acid amplification tests, and the wider availability of antiviral treatments.
The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $1.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. This growth over the forecast period is propelled by factors such as the increasing implementation of routine HSV screening programs, a growing need for rapid point-of-care molecular testing, the broadening of precision medicine strategies in infectious diseases, heightened healthcare investments across emerging markets, and continuous technological progress in multiplex and quantitative PCR platforms. Key developments expected during this period include a greater embrace of real-time PCR for swift HSV detection, a surge in the need for prompt diagnosis in neonatal and genital HSV infections, an expanded application of multiplex PCR assays for differentiating diagnoses, the wider availability of high-sensitivity quantitative PCR testing, and a progressive integration of automated sample-to-result systems.
Get A Free Sample Report With In-Depth Market Insights:
Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Demand Drivers Opening New Revenue Streams
The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market is projected to expand, driven by the escalating occurrence of infections. Infections refer to the entry and proliferation of detrimental microorganisms within the body, leading to illness. The rise in infections is attributable to urbanization, where increased population density in urban areas promotes the rapid transmission of pathogens via close human interaction and common resources. Herpes simplex virus (HSV) polymerase chain reaction (PCR) testing is beneficial as it swiftly and precisely identifies HSV DNA, facilitating prompt diagnosis and therapy, thereby averting the exacerbation or dissemination of the infection. An illustrative example is seen in 2023, where the UK Health Security Agency, a government body in the UK, reported a 4% increase in yeast-related bloodstream infections throughout England compared to 2022. Consequently, the growing frequency of infections is a primary catalyst for the expansion of the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market.
Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Segment Analysis: What Are The Core Market Categories?
The herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market covered in this report is segmented –
1) By Test Type: Polymerase Chain Reaction Testing, Serology Testing, Culture Testing
2) By Product Type: Instruments, Reagents And Kits, Software
3) By Sample Type: Vesicular Swabs or Fluid Samples, Cerebrospinal Fluid Samples, Blood or Serum Samples
4) By Application: Clinical Diagnostics, Research, Blood Screening, Other Applications
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Other End Users
Subsegments:
1) By Polymerase Chain Reaction Testing: Real Time Polymerase Chain Reaction, Nested Polymerase Chain Reaction, Multiplex Polymerase Chain Reaction, Quantitative Polymerase Chain Reaction
2) By Serology Testing: IgM Antibody Testing, IgG Antibody Testing, Western Blot Testing, Enzyme Linked Immunosorbent Assay
3) By Culture Testing: Cell Culture Isolation, Plaque Assay Culture, Shell Vial Culture, Tissue Culture Infection Assay
Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Trends Powering Strategic Industry Growth
Leading companies in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market are prioritizing the development of innovative solutions, such as point-of-care molecular diagnostics, to enable rapid, accurate, and decentralized detection of HSV infections for improved patient management. Point-of-care molecular diagnostics are tests designed to swiftly and precisely identify pathogens at the patient’s location without the necessity of a central laboratory. For example, in January 2023, Molbio Diagnostics Pvt. Ltd., an India-based medical technology firm, introduced a Truenat HSV 1/2 chip-based RT-PCR test specifically for diagnosing herpes simplex virus types 1 and 2. This portable, point-of-care assay provides results in under one hour from genital swabs or cerebrospinal fluid (CSF) using the battery-operated Truelab platform, requires no additional equipment, and holds central drugs standard control organisation (CDSCO) approval in India. It aims to support the rapid detection of active herpes simplex virus (HSV) infections, thereby boosting awareness and facilitating early treatment amidst a growing number of cases.
Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Top Companies Driving Competitive Growth
Major companies operating in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton, Dickinson Company, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Promega Corporation, Meridian Bioscience Inc., Seegene Inc., BioPerfectus Technologies Co. Ltd., altona Diagnostics GmbH, Xi’an Tianlong Science & Technology Co. Ltd., 3B BlackBio Dx Limited, GeneProof s.r.o., Primerdesign Ltd., BioHelix Corporation.
View The Full Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Report:
Herpes Simplex Virus (HSV) Polymerase Chain Reaction (PCR) Testing Market Global Footprint: Which Region Leads The Industry?
North America was the largest region in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the herpes simplex virus (HSV) polymerase chain reaction (PCR) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

